CELLnTEC Advanced Cell Systems Company Profile

11:36 EDT 18th March 2018 | BioPortfolio

CELLnTEC's expertise with the development of epithelial progenitor cell culture systems is also available thorugh a selection of unique services.


Laenggassstr 122


Phone: 41 (0)31 631 2508
Fax: 41 (0)31 631 2635

News Articles [2250 Associated News Articles listed on BioPortfolio]

MD Anderson, Berkeley Lights Launch Cancer Cell Therapy Company

The University of Texas MD Anderson Cancer Center and Berkeley Lights said today they have launched a new biopharma focused on developing cancer cell therapies discovered at MD Anderson, and manufactu...

Advanced Cell Technology:Gary Rabin. Applying Stem Cell-Based Technologies to Create Patient-Specific Therapies

In this episode of PharmaTelevision News Review, filmed at BioEurope Spring 2013, in Barcelona, Spain, Fintan Walton talks to Gary Rabin, CEO of Advanced Cell Technology

First-line Pazopanib May Improve Outcomes in Advanced RCC

Treatment-naïve patients with advanced clear-cell renal cell carcinoma had significantly longer progression-free survival when treated with pazopanib instead of temsirolimus.

New book on Cell-Cell Junctions published by CSHLPress

(Cold Spring Harbor Laboratory Press) "Cell-Cell Junctions, Second Edition", published by Cold Spring Harbor Laboratory Press, reviews our understanding of the organization, regulation, and dynamics o...

CGT Catapult to support UK network of advanced treatment centres

'World First' centres will develop and deliver systems for the delivery of cutting edge cell and gene therapies

FDA Approves Advanced Renal Cell Carcinoma Treatment

Officials with the FDA recently approved cabozantinib (Cabometyx) for the first-line treatment of patients with advanced renal cell carcinoma (RCC), according to a press release. 

Bio-Techne enters Genomics market with $250M acquisition of Advanced Cell Diagnostics

Bio-Techne Corporation have agreed to acquire California-based molecular pathology company Advanced Cell Diagnostics for $250 million in cash plus additional potential milestone payments of up to $75M...

Don't judge a cell by its cover: heterogeneity within early lymphoid progenitors

B-cell differentiation is one of the most recognized examples of the progressive lineage commitment that is distinctive for stem cell systems. However, the characteristics of the stage just before a c...

PubMed Articles [5535 Associated PubMed Articles listed on BioPortfolio]

Guidelines for Developing Successful Short Advanced Courses in Systems Medicine and Systems Biology.

Encapsulated Optically Responsive Cell Systems: Toward Smart Implants in Biomedicine.

Managing increasingly prevalent chronic diseases will require close continuous monitoring of patients. Cell-based biosensors may be used for implantable diagnostic systems to monitor health status. Ce...

Guidelines for Developing Successful Short Advanced Courses in Systems Medicine and Systems Biology.

Systems medicine and systems biology have inherent educational challenges. These have largely been addressed either by providing new masters programs or by redesigning undergraduate programs. In contr...

Assessing Inequality in Transcriptomic Data.

Two studies in this issue of Cell Systems use the Gini index from economics to benchmark and quantify gene expression heterogeneity in single-cell or bulk RNA-seq datasets.

Well-Controlled Cell-Trapping Systems for Investigating Heterogeneous Cell-Cell Interactions.

Microfluidic systems have been developed for patterning single cells to study cell-cell interactions. However, patterning multiple types of cells to understand heterogeneous cell-cell interactions rem...

Clinical Trials [10692 Associated Clinical Trials listed on BioPortfolio]

Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

The purpose of the study is to compare the clinical benefit, as measured by duration of overall survival, of Nivolumab vs. Everolimus in subjects with advanced or metastatic clear-cell ren...

A Phase 1 Study of the Clinical and Immunologic Effects of ALT-803 in Patients With Advanced Solid Tumors

The proposed clinical trial is a phase I, open-label, multi-center, dose-escalation study of ALT-803 in patients with surgically incurable advanced solid tumors: melanoma, renal cell, non-...

Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcom...

Trial of X4P--001 in Patients With Advanced Renal Cell Carcinoma

The purpose of the study is to test different doses of X4P-001 given alone and in combination with axitinib in patients diagnosed with advanced renal cell carcinoma. The goals of the study...

A Phase II Study to Treat Subjects With Advanced Renal Cell Carcinoma

The purpose of this study is to evaluate the effectiveness and safety of AMG 102 in patients with Advanced Renal Cancer.

Companies [3163 Associated Companies listed on BioPortfolio]

CELLnTEC Advanced Cell Systems

CELLnTEC's expertise with the development of epithelial progenitor cell culture systems is also available thorugh a selection of unique services.

One Cell Systems, Inc.

One Cell Systems is developing and marketing a family of single cell assays that rely on microencapsulation and flow cytometry. Technology underlying these products has been developed internally and l...

Biological Industries USA

Biological Industries ( is one of the world’s leading and trusted suppliers to the life sciences industry, with over 35 years’ experience in cell culture ...


ADVANCED CELL & GENE THERAPY, LLC, is a consulting firm serving biotechnology companies, clinical laboratories, and biotechnology investors. We provide practical, experienced guidance in development, ...

Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit http://www.advancedcell.c...

More Information about "CELLnTEC Advanced Cell Systems" on BioPortfolio

We have published hundreds of CELLnTEC Advanced Cell Systems news stories on BioPortfolio along with dozens of CELLnTEC Advanced Cell Systems Clinical Trials and PubMed Articles about CELLnTEC Advanced Cell Systems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CELLnTEC Advanced Cell Systems Companies in our database. You can also find out about relevant CELLnTEC Advanced Cell Systems Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record